These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20085115)

  • 1. Neurofibromatosis 2--a family journey.
    Clarke L
    Can J Neurosci Nurs; 2009; 31(4):7-14. PubMed ID: 20085115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
    Evans DG; Baser ME; O'Reilly B; Rowe J; Gleeson M; Saeed S; King A; Huson SM; Kerr R; Thomas N; Irving R; MacFarlane R; Ferner R; McLeod R; Moffat D; Ramsden R
    Br J Neurosurg; 2005 Feb; 19(1):5-12. PubMed ID: 16147576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 2: genetic and clinical features.
    Evans DG
    Ear Nose Throat J; 1999 Feb; 78(2):97-100. PubMed ID: 10089694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
    Evans DG; Watson C; King A; Wallace AJ; Baser ME
    J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis type 2].
    Pérez-Grau M; Miró N; Prades J; Vergés J; Lareo S; Roca-Ribas F
    Acta Otorrinolaringol Esp; 2010; 61(4):306-11. PubMed ID: 20138250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
    Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
    Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis: a guide to care in the community.
    Redmann C
    J Fam Health Care; 2007; 17(3):95-7. PubMed ID: 17849773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NF2: ocular, neural and genetic manifestations].
    Feucht M; Mautner VF; Richard G
    Klin Monbl Augenheilkd; 2005 Apr; 222(4):312-6. PubMed ID: 15844040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should NF2 mutation screening be undertaken in patients with an apparently isolated vestibular schwannoma?
    Evans DG; Ramsden RT; Gokhale C; Bowers N; Huson SM; Wallace A
    Clin Genet; 2007 Apr; 71(4):354-8. PubMed ID: 17470137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management strategies in neurofibromatosis type 2.
    Moffat DA; Quaranta N; Baguley DM; Hardy DG; Chang P
    Eur Arch Otorhinolaryngol; 2003 Jan; 260(1):12-8. PubMed ID: 12520350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma development.
    Woods R; Friedman JM; Evans DG; Baser ME; Joe H
    Genet Epidemiol; 2003 May; 24(4):265-72. PubMed ID: 12687643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
    Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
    Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 2 in an infant with multiple plexiform schwannomas as first symptom.
    Miyakawa T; Kamada N; Kobayashi T; Hirano K; Fujii K; Sasahara Y; Nagai Y; Shinkai H
    J Dermatol; 2007 Jan; 34(1):60-4. PubMed ID: 17204104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity.
    Parry DM; Eldridge R; Kaiser-Kupfer MI; Bouzas EA; Pikus A; Patronas N
    Am J Med Genet; 1994 Oct; 52(4):450-61. PubMed ID: 7747758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral vestibular schwannomas in older patients: NF2 or chance?
    Evans DG; Freeman S; Gokhale C; Wallace A; Lloyd SK; Axon P; Ward CL; Rutherford S; King A; Huson SM; Ramsden RT;
    J Med Genet; 2015 Jun; 52(6):422-4. PubMed ID: 25725045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.